Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Ji · SciRah

Researcher profile · Semantic Scholar

D. Ji

Share profile

D. Ji — researcher profile on SciRah

h-index: 19
Works: 109
Citations: 1,688

Most-cited papers

Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial.
Jin Li, S. Qin, Jian-Ming Xu, Wei-Jian Guo +14 more
2013Journal of Clinical Oncology484 citations Open access
Semantic Scholar
Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma
W. Pu, Xiao Shi, Peng-cheng Yu, Meiying Zhang +17 more
2021Nature Communications207 citations Open access
Semantic Scholar
Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.
Bing Zheng, J. Mao, Lin Qian, Hua Zhu +4 more
2015Cancer Letters113 citations
Semantic Scholar
Functional Genetic Approach Identifies MET, HER3, IGF1R, INSR Pathways as Determinants of Lapatinib Unresponsiveness in HER2-Positive Gastric Cancer
Zhe Zhang, Jiping Wang, D. Ji, Chen-Chen Wang +9 more
2014Clinical Cancer Research69 citations
Semantic Scholar
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B‐cell lymphoma patients who are HBsAg‐negative/ HBcAb‐positive: a multicenter retrospective study
D. Ji, Jun-Ning Cao, X. Hong, Jun-min Li +4 more
2010European Journal of Haematology69 citations
Semantic Scholar
First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study.
Jian Zhang, D. Ji, L. Cai, H. Yao +15 more
2021Clinical Cancer Research65 citations Open access
Semantic Scholar
Phase I Trial of a Novel Anti-HER2 Antibody-drug Conjugate, ARX788, for the Treatment of HER2-positive Metastatic Breast Cancer.
Jian Zhang, D. Ji, W. Shen, Qin Xiao +3 more
2022Clinical Cancer Research55 citations Open access
Semantic Scholar
The Combination of RAD001 and MK-2206 Exerts Synergistic Cytotoxic Effects against PTEN Mutant Gastric Cancer Cells: Involvement of MAPK-Dependent Autophagic, but Not Apoptotic Cell Death Pathway
D. Ji, Zhe Zhang, Lei Cheng, Jinjia Chang +11 more
2014PLoS ONE47 citations Open access
Semantic Scholar
Induction Toripalimab And Chemotherapy For Organ Preservation In Locally Advanced Laryngeal And Hypopharyngeal Cancer: A Single-Arm Phase 2 Clinical Trial.
X. Ou, R. Zhai, Wenjun Wei, Jia-Ying Chen +24 more
2023Clinical Cancer Research37 citations
Semantic Scholar
The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy
Chen-Chen Wang, Weijian Guo, Min Zhou, Xiaodong Zhu +7 more
2015Clinical Cancer Research30 citations
Semantic Scholar
Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
L. Gui, Jun-Ning Cao, D. Ji, Hui-Lai Zhang +7 more
2021Chinese journal of cancer research = Chung-kuo yen cheng yen chiu26 citations Open access
Semantic Scholar
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial.
Pan-Pan Zhang, Si Shi, Jianming Xu, Zhen-Dong Chen +26 more
2024European Journal of Cancer25 citations Open access
Semantic Scholar
A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus
Jia-Lei Wang, Jian-Hua Chang, Hui Yu, Xiang-Hua Wu +4 more
2013Cancer Chemotherapy and Pharmacology25 citations
Semantic Scholar
Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial
X. Qin, D. Ji, W. Gu, W. Han +14 more
2022BMC Medicine21 citations Open access
Semantic Scholar
Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1.
Ya'nan Yang, Chen-Chen Wang, Congqi Dai, Xin-Yang Liu +6 more
2021Acta Biochimica et Biophysica Sinica21 citations
Semantic Scholar
Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial
Zhiyu Chen, Wei-Jian Guo, Jun-Ning Cao, F. Lv +8 more
2015Cancer Chemotherapy and Pharmacology21 citations
Semantic Scholar
Safety and unique pharmacokinetic profile of ARX788, a site-specific ADC, in heavily pretreated patients with HER2-overexpresing solid tumors: Results from two phase 1 clinical trials.
S. Hurvitz, Haeseong Park, S. Frentzas, Catherine M. Shannon +16 more
2021Journal of Clinical Oncology20 citations
Semantic Scholar
First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutations
Xuan Wang, Zhiguo Luo, Jing Chen, Yu Chen +9 more
2023BMC Medicine19 citations Open access
Semantic Scholar
USP18 and USP20 restrict oHSV-1 replication in resistant human oral squamous carcinoma cell line SCC9 and affect the viability of SCC9 cells
Ruitao Lu, Guangxian Wu, Meiling Chen, D. Ji +3 more
2021Molecular Therapy: Oncolytics19 citations Open access
Semantic Scholar
Phase 1 Dose Escalation and Expansion Study of Golidocitinib, a Highly Selective JAK1 Inhibitor, in Relapsed or Refractory Peripheral T Cell Lymphomas.
Y. Song, D. Yoon, H. Yang, J. Cao +13 more
2023Annals of Oncology18 citations Open access
Semantic Scholar
A phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors.
D. Ji, Y. weitao, Xiang-Min Tong, Chen-Ping Zhang +16 more
2023Journal of Clinical Oncology17 citations
Semantic Scholar
Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen
Ru-Jiao Liu, Ming-Zhu Huang, Xiao-Ying Zhao, Wei Peng +8 more
2015OncoTarget15 citations Open access
Semantic Scholar
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models
Xusha Zhou, Jing Zhao, Jian V. Zhang, Yinglin Wu +4 more
2021Viruses14 citations Open access
Semantic Scholar
Abstract P1-18-16: A phase 1 study of ARX788, a HER2-targeting antibody-drug conjugate, in patients with metastatic HER2-positive breast cancer
Xi-Chun Hu, Jian Zhang, D. Ji, Gang Xia +3 more
202013 citations
Semantic Scholar
Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials
K. Zhou, Ming-Yuan Sun, Xu Wei, S. Yi +32 more
2023Blood12 citations Open access
Semantic Scholar
Preliminary safety, efficacy and pharmacokinetics (PK) results of KN026, a HER2 bispecific antibody in patients (pts) with HER2-positive metastatic breast cancer.
D. Ji, Jian Zhang, W. Shen, Yi-Qun Du +6 more
2020Journal of Clinical Oncology12 citations
Semantic Scholar
Phase I Pharmacokinetic Study of Niraparib in Chinese Patients with Epithelial Ovarian Cancer.
Jian Zhang, Hong Zheng, Yunong Gao, G. Lou +12 more
2019The Oncologist12 citations Open access
Semantic Scholar
The size and depth of lesions measured by endoscopic ultrasonography are novel prognostic factors of primary gastric diffuse large B-cell lymphoma
Yi-Zhen Liu, K. Xue, Bo-Shi Wang, Chun-Yan Li +10 more
2018Leukemia and Lymphoma12 citations
Semantic Scholar
Histone Deacetylase Inhibitor Panobinostat Benefits the Therapeutic Efficacy of Oncolytic Herpes Simplex Virus Combined with PD-1/PD-L1 Blocking in Glioma and Squamous Cell Carcinoma Models
Yinglin Wu, Xiaoqing Chen, Lei Wang, Xusha Zhou +5 more
2022Viruses11 citations Open access
Semantic Scholar
Neoadjuvant famitinib and camrelizumab, a new combined therapy allowing surgical resection of the primary site for anaplastic thyroid carcinoma
Shu-Wen Yang, D. Ji, F. Xue, Tong-Zhen Chen +2 more
2022Cancer Reports10 citations Open access
Semantic Scholar
Baseline monocyte and its classical subtype may predict efficacy of PD-1/PD-L1 inhibitor in cancers
Y. Shao, Shu-chen Lin, Ping Zhang, Jian Zhang +3 more
2021Bioscience Reports10 citations Open access
Semantic Scholar
Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study
D. Ji, Qiu Li, Jun-Ning Cao, Ye Guo +8 more
2016OncoTarget9 citations Open access
Semantic Scholar
Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors
Xiao-Dong Zhu, Xiao-Ying Zhao, Wei Peng, Si Sun +9 more
2014Journal of Cancer Research and Clinical Oncology9 citations Open access
Semantic Scholar
Prognostic significance of clinical characteristics and 18Fluorodeoxyglucose-positron emission tomography/computed tomography quantitative parameters in patients with primary mediastinal B-cell lymphoma
Yi-Zhen Liu, Jin-Jin Jiang, Lian-Fang Liu, Zezhou Wang +9 more
2022Journal of International Medical Research8 citations Open access
Semantic Scholar
A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic Cancers
Jian Zhang, N. Yang, D. Ji, W. Shen +8 more
2021Targeted oncology8 citations Open access
Semantic Scholar
Next-Generation Sequencing Enhances the Diagnosis Efficiency in Thyroid Nodules
Li-Cheng Tan, Wan-Lin Liu, Xiao-Li Zhu, Peng-cheng Yu +10 more
2021Frontiers in Oncology8 citations Open access
Semantic Scholar
Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trials
C. Mao, D. Ji, Y. Ding, Y. Zhang +8 more
2023ESMO Open7 citations Open access
Semantic Scholar
Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial.
Jun-Ning Cao, Hong-Qian Guo, D. Ji, W. Shen +7 more
2023The Oncologist7 citations Open access
Semantic Scholar
Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial
Jia Jin, D. Ji, Z. Xia, K. Xue +7 more
2022BMC Cancer7 citations Open access
Semantic Scholar
High accumulation of Mx2 renders limited multiplication of oncolytic herpes simplex virus-1 in human tumor cells
Youzhong Ren, Meiling Chen, Guang-Jer Wu, D. Ji +3 more
2021Scientific Reports7 citations Open access
Semantic Scholar
A phase 1b study of VEGFR inhibitor fruquintinib in patients with pretreated advanced colorectal cancer.
Jin Li, Jun-Ning Cao, Rui-Hua Xu, Zhiyu Chen +6 more
20147 citations
Semantic Scholar
Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab.
Bing Cao, Xiaoyan Zhou, D. Ji, Jun-Ning Cao +9 more
2012Oncology Letters7 citations Open access
Semantic Scholar
Pooled analysis of phase I dose-escalation and dose cohort expansion studies of IMP4297, a novel PARP inhibitor, in Chinese and Australian patients with advanced solid tumors.
Jun-Ning Cao, Pin Zhang, P. de Souza, B. Gao +16 more
2019Journal of Clinical Oncology6 citations
Semantic Scholar
A phase II multicenter trial of the multitargeted kinase inhibitor sulfatinib in advanced medullary thyroid cancer (MTC) and radioiodine (RAI)-refractory differentiated thyroid cancer (DTC).
Jia-Ying Chen, Q. Ji, Jun-Ning Cao, D. Ji +7 more
20176 citations
Semantic Scholar
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
Qunling Zhang, Jun-Ning Cao, K. Xue, Xiao-Jian Liu +3 more
2016OncoTargets and Therapy6 citations Open access
Semantic Scholar
Liposomal irinotecan (HR070803) in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors: a phase 1b dose-escalation and expansion study
D. Ji, W. Shen, Ting Li, Huan Wang +3 more
2024Investigational new drugs5 citations Open access
Semantic Scholar
Induction chemotherapy and toripalimab for larynx preservation in resectable locally advanced laryngeal/hypopharyngeal carcinoma: Preliminary results of INSIGHT study.
X. Ou, Xia-Yun He, Yu Wang, Xue-Guan Lu +4 more
2023Journal of Clinical Oncology5 citations
Semantic Scholar
Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin Lymphoma: Real-World Data in Chinese Population
Zixun Yan, D. Zou, Yu-Hua Li, Xiao-Jian Zhu +14 more
2023Blood4 citations Open access
Semantic Scholar
Abstract PD8-04: Safety and anti-tumor activity of ARX788 in HER2-positive metastatic breast cancer patients whose disease is resistant/refractory to HER2 targeted agents (trastuzumab, ADCs, TKIs, and bispecific antibodies): ACE-Breast-01 trial results
Jiangwen Zhang, D. Ji, W. Shen, Qin Xiao +11 more
2022Cancer Research4 citations
Semantic Scholar
EARLY SAFETY AND EFFICACY DATA FROM A PHASE I/II TRIAL OF DZD4205, A SELECTIVE JAK1 INHIBITOR, IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA
W. Kim, D. Yoon, Yu-Qin Song, Y. Koh +16 more
2021Hematological Oncology4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Jun-Ning Cao×11
Invite
Jun-Ning Cao — researcher profile on SciRah
W. Shen×10
Invite
W. Shen — researcher profile on SciRah
Xi-Chun Hu×10
Invite
Xi-Chun Hu — researcher profile on SciRah
Jian Zhang×9
Invite
Jian Zhang — researcher profile on SciRah

×7

Invite

Jin Li — researcher profile on SciRah

Invite

X. Hong — researcher profile on SciRah

Chen-Chen Wang×6

Invite

Chen-Chen Wang — researcher profile on SciRah

Invite

Wen-hua Li — researcher profile on SciRah

Invite

F. Lv — researcher profile on SciRah

Qunling Zhang×5

Invite

Qunling Zhang — researcher profile on SciRah

Invite

Xin Liu — researcher profile on SciRah

Invite

Q. Ji — researcher profile on SciRah